WCN26-4211 Hematopoietic Stem Cell Gene Editing as a Therapeutic Approach for IgA Nephropathy

Read full text Summarise with VIRAT
Authors: Mayumi Takahashi-Kobayashi, Joichi Usui, Satoshi Yamazaki
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

IgA nephropathy (IgAN) is the most common form of chronic glomerulonephritis in Japan, yet no curative therapy is currently available. Accumulating evidence suggests that IgAN is driven by the production of abnormally glycosylated IgA and subsequent formation of pathogenic immune complexes. This raises the possibility that eliminating or correcting the source of aberrant IgA could achieve a true cure. Notably, reports of IgAN recurrence after kidney transplantation and remission following bone marrow transplantation point to a critical role of the hematopoietic system in disease pathogenesis.

Fields of Study & Subjects

Renal Diseases and Glomerulopathies Complement system in diseases Renal Transplantation Outcomes and Treatments

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105061–105061
Publication date
25 March 2026
Language
EN